First Peanut Allergy Drug Gets FDA Thumbs Up

Palforzia is now approved for use in individuals aged 4 through 17 who have a confirmed diagnosis of peanut allergy.

Source: Forbes.com Healthcare News - February 6, 2020 Category: Pharmaceuticals Authors: Dana Dovey, Contributor Source Type: news